Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

Dithiocarbamates and iron chelators were recently considered for the treatment of AIDS and neurodegenerative diseases. In this study, we show that dithiocarbamates and metal chelators can potently block the activation of nuclear factor kappa B (NF-kappa B), a transcription factor involved in human immunodeficiency virus type 1 (HIV-1) expression, signaling, and immediate early gene activation during inflammatory processes. Using cell cultures, the pyrrolidine derivative of dithiocarbamate (PDTC) was investigated in detail. Micromolar amounts of PDTC reversibly suppressed the release of the inhibitory subunit I kappa B from the latent cytoplasmic form of NF-kappa B in cells treated with phorbol ester, interleukin 1, and tumor necrosis factor alpha. Other DNA binding activities and the induction of AP-1 by phorbol ester were not affected. The antioxidant PDTC also blocked the activation of NF-kappa B by bacterial lipopolysaccharide (LPS), suggesting a role of oxygen radicals in the intracellular signaling of LPS. This idea was supported by demonstrating that treatment of pre-B and B cells with LPS induced the production of O2- and H2O2. PDTC prevented specifically the kappa B-dependent transactivation of reporter genes under the control of the HIV-1 long terminal repeat and simian virus 40 enhancer. The results from this study lend further support to the idea that oxygen radicals play an important role in the activation of NF-kappa B and HIV-1.

[1]  K. Nose,et al.  Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. , 1991, European journal of biochemistry.

[2]  D. Baltimore,et al.  Rel-associated pp40: an inhibitor of the rel family of transcription factors. , 1991, Science.

[3]  Y. Ben-Neriah,et al.  Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum , 1991, Cell.

[4]  P. Baeuerle,et al.  A role for oxygen radicals as second messengers. , 1991, Trends in cell biology.

[5]  A. Nègre-Salvayre,et al.  Protective effect of α-tocopherol, ascorbic acid and rutin against peroxidative stress induced by oxidized lipoproteins on lymphoid cell lines , 1991 .

[6]  S. Haskill,et al.  Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity , 1991, Cell.

[7]  R. Redfield,et al.  Anoxia induces human immunodeficiency virus expression in infected T cell lines. , 1991, The Journal of biological chemistry.

[8]  D. Parke,et al.  Free radicals in biology and medicine (2nd Edition) : By Barry Halliwell and John M.C. Gutteridge; Clarendon Press; Oxford, 1989; xvi + 543 pages; £50.00 (cloth), £22.50 (paperback) , 1991 .

[9]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[10]  R. Kurth,et al.  Inhibition of HIV‐1 replication and NF-x B activity by cysteine and cysteine derivatives , 1991, AIDS.

[11]  M. Karin,et al.  Rapid and preferential activation of the c-jun gene during the mammalian UV response , 1991, Molecular and cellular biology.

[12]  J. W. Rooney,et al.  Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. , 1991, Cell regulation.

[13]  J. Bartlett,et al.  Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. , 1991, JAMA.

[14]  G. Englund,et al.  A novel HIV-1 isolate containing alterations affecting the NF-κB element , 1991 .

[15]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[16]  A. Fauci,et al.  Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Pincemail,et al.  Activation of human immunodeficiency virus type 1 by oxidative stress. , 1990, AIDS research and human retroviruses.

[18]  M. Roederer,et al.  Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Habermehl,et al.  Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. , 1990, Biological chemistry Hoppe-Seyler.

[20]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[21]  L. Pauling,et al.  Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Baltimore,et al.  Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression , 1990, The Journal of experimental medicine.

[23]  M. Roederer,et al.  Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Hensel,et al.  Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor. , 1990, The Journal of biological chemistry.

[25]  G. Storz,et al.  Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. , 1990, Science.

[26]  D. Baltimore,et al.  Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" , 1990, Nature.

[27]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[28]  M. Dietrich,et al.  Inhibition of HIV progression by dithiocarb , 1990, The Lancet.

[29]  P. Baeuerle,et al.  NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene , 1990, Molecular and cellular biology.

[30]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[31]  A. Fauci,et al.  Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. , 1990, Immunology today.

[32]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1990, Nature.

[33]  Shakhov,et al.  KBTYPE ENHANCERS ARE INVOLVED IN LIPOPOLYSACCHARIDE-MEDIATED TRANSCRIPTIONAL ACTIVATION OF THE TUMOR NECROSIS FACTOR a GENE IN PRIMARY MACROPHAGES BY , 1990 .

[34]  M. Vigneron,et al.  The SV40 TC‐II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non‐lymphoid cell lines. , 1989, The EMBO journal.

[35]  P. Chambon,et al.  The SV40 TC‐II(kappa B) and the related H‐2Kb enhansons exhibit different cell type specific and inducible proto‐enhancer activities, but the SV40 core sequence and the AP‐2 binding site have no enhanson properties. , 1989, The EMBO journal.

[36]  G. Habermehl,et al.  Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. , 1989, The Biochemical journal.

[37]  G. Wong,et al.  Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.

[38]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. Dröge,et al.  Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. , 1989, Biological chemistry Hoppe-Seyler.

[40]  D. Goeddel,et al.  Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.

[41]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[42]  T. Taniguchi,et al.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements , 1988, Cell.

[43]  C. Dinarello,et al.  Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism , 1988, Cell.

[44]  D. Baltimore,et al.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor , 1988, Cell.

[45]  R. Renkawitz,et al.  Lysozyme gene activity in chicken macrophages is controlled by positive and negative regulatory elements. , 1987, Nucleic acids research.

[46]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1987, Nature.

[47]  J. Perchellet,et al.  Effects of diverse intracellular thiol delivery agents on glutathione peroxidase activity, the ratio of reduced/oxidized glutathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12‐O‐tetradecanoylphorbol‐13‐acetate , 1987, Journal of cellular physiology.

[48]  D. Männel,et al.  Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells. , 1987, Lymphokine research.

[49]  N. Thompson,et al.  Inhibition of phorbol ester stimulated superoxide production by 1‐oleoyl‐2‐acetyl‐sn‐glycerol (OAG); fact or artefact? , 1986, FEBS Letters.

[50]  A. DeFranco,et al.  Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. , 1986, Science.

[51]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[52]  J. Pocidalo,et al.  Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicity. , 1986, The Journal of pharmacology and experimental therapeutics.

[53]  R. Hirschelmann,et al.  Influence of the iron chelating agent desferrioxamine on two rat inflammatory models. , 1986, Free radical research communications.

[54]  F. Oberling,et al.  IMMUNOMODULATION WITH DIETHYLDITHIOCARBAMATE IN PATIENTS WITH AIDS-RELATED COMPLEX , 1985, The Lancet.

[55]  R. Meneghini,et al.  Protection of mammalian cells by o-phenanthroline from lethal and DNA-damaging effects produced by active oxygen species. , 1985, Biochimica et biophysica acta.

[56]  S. Fischer,et al.  Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism. , 1985, Cancer research.

[57]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[58]  C. Raetz,et al.  The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. , 1984, The Journal of biological chemistry.

[59]  P. Dieppe,et al.  Effect of a specific iron chelating agent on animal models of inflammation. , 1983, Annals of the rheumatic diseases.

[60]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[61]  D. Salomon,et al.  Specific receptors for phorbol esters in lymphoid cell populations: role in enhanced production of T-cell growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[62]  B. Fanburg,et al.  Involvement of glutathione enzymes in O2 tolerance development by diethyldithiocarbamate. , 1980, Biochemical pharmacology.

[63]  B. Halliwell,et al.  Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. , 1979, The Biochemical journal.

[64]  L. Flohé,et al.  Respiratory chain linked H2O2 production in pigeon heart mitochondria , 1971, FEBS letters.

[65]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[66]  Sunderman Fw,et al.  The effects of the protracted administration of the chelating agent, sodium diethyldithiocarbamate (dithiocarb). , 1967 .